» Articles » PMID: 29108330

Surgical Management for Follicular Variant of Papillary Thyroid Carcinoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Nov 8
PMID 29108330
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: For most patients with follicular variant of papillary thyroid carcinoma (FVPTC), surgery is required, while the surgical management remains controversial. We aim to further understanding of treatment of FVPTC and to determine whether specific features could be identified for the decision of surgical strategy.

Materials And Methods: Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program database during 2003 and 2013. 26700 patients were eligible and stratified by tumor size or extension. Survival rates were compared using multivariate Cox proportional hazard regressions.

Results: Of the total death of 1041, 136 patients died from thyroid cancer. Most patients (79.1%) underwent total thyroidectomy while only a little part of patients (8.2%) underwent lobectomy. Patients receiving radioisotopes had significantly better overall survival (OS) (HR = 0.659, < 0.001), but showed no differences on disease-specific survival (DSS). No statistical difference was found between total thyroidectomy and lobectomy in multivariate analysis when controlling for tumor size. While for tumor > 2 cm with extrathyroidal extension, lobectomy had significantly worse OS (aHR = 3.364, = 0.010) and DSS (aHR = 5.494, = 0.032) compared to total thyroidectomy. Multivariate analysis demonstrated that advanced age, male, higher grade, extrathyroidal extension, lymph nodes metastases and distant metastases had negative effects on OS and DSS controlling for the remaining variables (each < 0.05).

Conclusions: The results of our study revealed total thyroidectomy could benefit the survival for patients whose tumors > 2 cm with extrathyroidal extension, total thyroidectomy should be recommended for those patients. Lots of factors should be taken into consideration on the decision of surgical treatment.

Citing Articles

Breast metastasis of papillary thyroid carcinoma.

Worapongpaiboon R, Vongsaisuwon M BMJ Case Rep. 2022; 15(7).

PMID: 35793844 PMC: 9260778. DOI: 10.1136/bcr-2022-251081.


A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies.

Ghanbari-Movahed M, Jackson G, Farzaei M, Bishayee A Front Pharmacol. 2021; 12:639840.

PMID: 33854437 PMC: 8039459. DOI: 10.3389/fphar.2021.639840.

References
1.
Liu J, Singh B, Tallini G, Carlson D, Katabi N, Shaha A . Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006; 107(6):1255-64. DOI: 10.1002/cncr.22138. View

2.
Chan J . Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117(1):16-8. DOI: 10.1309/P7QL-16KQ-QLF4-XW0M. View

3.
Vaisman F, Shaha A, Fish S, Tuttle R . Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol (Oxf). 2011; 75(1):112-9. DOI: 10.1111/j.1365-2265.2011.04002.x. View

4.
Chang H, Lin J, Chou S, Chao T, Hsueh C . Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J Clin Oncol. 2006; 36(11):688-93. DOI: 10.1093/jjco/hyl093. View

5.
Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A . Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 2003; 97(5):1181-5. DOI: 10.1002/cncr.11175. View